InvestorsHub Logo
Followers 698
Posts 59465
Boards Moderated 18
Alias Born 06/01/2008

Re: None

Sunday, 09/02/2018 6:29:10 PM

Sunday, September 02, 2018 6:29:10 PM

Post# of 1951

Corporate Financings and Other Matters

On April 13, 2018, CannaRoyalty announced that it has closed a $15.0 million bought deal prospectus
financing, for an aggregate of 3,750,000 units of the Company at a price of $4.00 Per Unit.

On April 18, 2018, the Company announced that it had exercised an over-allotment option in connection
with the $15.0 million bought deal. CannaRoyalty issued an additional 562,500 units at $4.00 per Unit
for additional gross proceeds of $2.3 million. Following closing of the over-allotment option, the
Company has raised aggregate gross proceeds of $17.3 million.

On June 19, 2018, the Company announced that it was undertaking a fully marketed brokered private
placement of unsecured convertible debentures to raise gross proceeds of up to $30.0 million, which
would be utilized towards fuelling development of seven facilities across California. Further details
regarding the financing are set out below under the heading “Recent Developments – Corporate
Financings”.

FINANCIAL PERFORMANCE

The following are the major financial highlights of CannaRoyalty’s operating results for the three months
ended June 30, 2018, compared to the three months ended June 30, 2017:

• revenues were $3.5 million as compared to $960,157, an increase of 266%;

• gross margin was $820,935 as compared $421,681, an increase of 95%;

• operating expenses were $6.3 million as compared to $2.7 million, an increase of 129%;

• net income of $9.3 million as compared to a net loss of $2.0 million;

• net income per basic share of $0.18 as compared to a net loss per basic share of $0.05;

• net income per diluted share of $0.17 as compared to a net loss per diluted share of $0.05;

• adjusted EBITDA income of $11.1 million as compared to a loss of $1.0 million, an increase of
$12.1 million; and

• adjusted EBITDA income per basic share of $0.21 as compared to a loss of $0.02, an increase of
$0.23 per basic share.

• adjusted EBITDA income per diluted share of $0.20 as compared to a loss of $0.02, an increase
of $0.22 per diluted share.

The following is a summary of key balance sheet totals as at June 30, 2018 compared to December 31,
2017.

• cash was $15.7 million as compared to $4.5 million an increase of 248%;

• total assets of $94.8 million as compared to $46.1 million, an increase of 105%;

• current assets of $23.5 million as compared to $7.9 million, an increase of 196%;

• current liabilities of $5.9 million as compared to $2.1 million, an increase of 178%; and

• long-term debt of $290,457 as compared to $2.3 million, a decrease of 87%.

RECENT DEVELOPMENTS

Subsequent event highlights:

• On July 2, 2018, the Company acquired 100% of FloraCal, a licensed ultra-premium craft cannabis
producer located in Sonoma Country, California.

• On July 12, 2018, the Company announced that it closed a previously announced private placement
for gross proceeds of $33.0 million.

• On August 8, 2018, an investee of the Company, Anandia, was acquired by Aurora Cannabis Inc. for
approximately $115 million. CannaRoyalty’s equity stake in Anandia is fair valued at approximately
$17.0 million.

• A payment of $438,338 was received in connection with the previously impaired BAS Promissory
Notes in August 2018.

• On August 13, 2018, the Company closed the sale of a Canadian license to use and commercialize
the pre-roll technology developed by Wagner Dimas to Aurora Cannabis Inc. valued at $7.0 million.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.